Selection and evaluation of anticholinergics for transdermal drug delivery

International Journal of Pharmaceutics

Volumn 169, Issue 1, 1998, Pages 75-82

  Bosman, Ingrid J ^a,b   Ensing, Kees ^a   De Zeeuw, Rokus A ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Anticholinergics; In vitro permeation; Physicochemical characteristics; Receptor affinities; Transdermal delivery

Indexed keywords

ADIPHENINE; ATROPINE; BENZATROPINE MESILATE; BIPERIDEN; CHOLINERGIC RECEPTOR BLOCKING AGENT; DEXETIMIDE; DICYCLOVERINE; HOMATROPINE; METIXENE; ORPHENADRINE; OXYPHENCYCLIMINE; PIRENZEPINE; PROCYCLIDINE; PROFENAMINE; SCOPOLAMINE BROMIDE; TERODILINE; TRIHEXYPHENIDYL; TROPICAMIDE;

ARTICLE; CHEMICAL STRUCTURE; DISSOCIATION CONSTANT; DRUG DELIVERY SYSTEM; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; MOLECULAR WEIGHT; PARTITION COEFFICIENT; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RADIORECEPTOR ASSAY; RECEPTOR AFFINITY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032581238     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00107-0     Document Type: Article

References (15)

1. Amlacher, R., Härtl, A., Neubert, R., Stöckel, U., Wenzel, K., 1991. Influence of ion-pair formation on the pharmacokinetic properties of drugs. Pharmacokinetic interactions of bretylium and hexylsalicylic acid in rabbits. J. Pharm. Pharmacol. 43, 794-797.
2. Barry, B.W., 1993. Basic principles of diffusion through membranes. In: Dermatological Formulations: Percutaneous Absorption. Marcel Dekker, New York, pp. 49-94.
3. Bosman, I.J., Ensing, K., deZeeuw, R.A., 1998. Standardization procedure for the in vitro skin permeation of anticholinergics. Int. J. Pharm. 1, 65-73.
4. Budavari, S., O'Neil, M.J., Smith, A., Heckelman, P.E. (Eds.), 1989. The Merck Index. An Encyclopedia of Chemicals, Drugs, and Biologicals, 11th ed. Merck, Rahway, NJ.
5. Ensing, K., Bosman, I.J., Egberts, A.C.G., Franke, J.P., de Zeeuw, R.A., 1994. Application of radioreceptor assays for systematic toxicological analysis. 1. Procedures for radioreceptor assays for antihistaminics, anticholinergics and benzodiazepines. J. Pharm. Biomed. Anal. 12, 53-58.
6. Franz, T.J., 1983. Kinetics of cutaneous drug penetration. Int. J. Dermatol. 22, 499-505.
7. Guy, R.H., Hadgraft, J., 1986. Transdermal drug delivery: the ground rules are emerging. Pharm. Int. May, 112-116.
8. Moffat, A.C., Jackson, J.V., Moss, M.S., Widdop, B., Greenfield, E.S. (Eds.), 1986. Clarke's Isolation and Identification of Drugs in Pharmaceuticals, Body Fluids, and Post-mortem Material, 2nd ed. The Pharmaceutical Press, London.
9. Munson, P.J., Rodbard, D., 1980. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
10. Pakes, G.E., Brodgen, R.N., Heel, R.C., Speight, T.M., Avery, G.S., 1980. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20, 237-266.
11. Reynolds, J.E.F., Parfitt, K., Parsons, A.V., Sweetman S.C. (Eds), 1989. Martindale. The Extra Pharmacopoeia, 29th ed. The Pharmaceutical Press, London.
12. Smith, K.L., 1990. Penetrant characteristics influencing skin absorption. In: Kemppainen, B.W., Reifenrath, W.G. (Eds.), Methods for Skin Absorption. CRC Press, Florida, pp. 23-34.
13. Swart, P.J., Weide, W.L., de Zeeuw, R.A., 1992. In vitro penetration of the dopamine D2 agonist N-0923 with and without Azone. Int. J. Pharm. 87, 67-72.
14. Tenjarla, S.N., Allen, R., Borazani, A., 1994. Evaluation of verapamil hydrochloride permeation through human cadaver skin. Drug Dev. Ind. Pharm. 20, 49-63.
15. Wiechers, J.W., 1989. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm. Weekbl. Sci. Ed. 11, 185-198.